Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,002 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Completed

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

NCT03667716

Conditions
Adnexal Diseases, Advanced Cancer, Breast Cancer, +44 more
Locations
  • University of California Los Angeles (UCLA). Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Nivolumab in Selected Uterine Cancer Patients

NCT03241745

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

UTOLA: UTerin OLAparib

NCT03745950

Conditions
Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • ICO Paul Papin Angers, France
  • Institut du cancer Avignon-Provence Avignon, France
  • CHRU Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details
Completed

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

NCT05712889

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +43 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
  • Macquarie University Macquarie Park, New South Wales, Australia
View Trial Details
Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details

Related conditions